PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-01-24

Date Title Company
24-Jan-2022 MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards' Gender Equality Index Report MorphoSys AG
24-Jan-2022 WuXi STA Launches its First Parenteral Formulation Manufacturing Line WuXi STA
24-Jan-2022 Explora BioLabs Launches Preclinical Vivarium Model in Seattle Newswire
24-Jan-2022 Atrial Fibrilillation Study by NativeCardio and the Texas Heart Institute Show Ultra-Low Cardioversion is Possible Newswire
24-Jan-2022 NICE EXPANDS GUIDANCE FOR LOKELMA®▼(sodium zirconium cyclosilicate) IN ADULT PATIENTS WITH PERSISTENT HYPERKALAEMIA AstraZeneca
24-Jan-2022 Cellvera Receives $20M Purchase Order for COVID-19 Oral Antiviral Avigan® Newswire
24-Jan-2022 Prime Global acquires HCD Economics, creating an innovative evidence-generating, HEOR, value & communications group Prime Global
24-Jan-2022 Original-Research: Defence Therapeutics Inc. (von GBC AG) Defence Therapeutics Inc.
24-Jan-2022 CD Genomics: The Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service CD Genomics
24-Jan-2022 Successful completion of FY/2021 with +34% growth in Q4 leading to significant sales increase in 2021 (+30%); further sales growth and EBITDA improvement planned for FY/2022 aap Implantate AG
24-Jan-2022 Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs RELIEF THERAPEUTICS Holding AG
24-Jan-2022 Supervisory Board of Epigenomics AG Retains Greg Hamilton as Chief Executive Officer Through Development of Epi proColon 'Next-Gen' Colorectal Cancer Screening Test Epigenomics AG